A pilot study of the safety and efficacy of dexamethasone, ifosfamide, methotrexate and gemcitabine chemotherapy for natural killer/T-cell lymphoma

Leukemia and Lymphoma

Volumn 56, Issue 7, 2015, Pages 2218-2221

  Yang, Jianliang ^a   Shi, Yuankai ^a   He, Xiaohui ^a   Dong, Mei ^a   Zhang, Changgong ^a   Liu, Peng ^a   Zhou, Shengyu ^a   Qin, Yan ^a   Gui, Lin ^a   Yang, Sheng ^a   Sun, Yan ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BILIRUBIN; DEXAMETHASONE; FOLIC ACID; GEMCITABINE; HEMOGLOBIN; IFOSFAMIDE; METHOTREXATE; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE;

ADULT; AGED; ANEMIA; ANOREXIA; BILIRUBIN BLOOD LEVEL; BONE MARROW BIOPSY; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTRANSAMINASEMIA; LETTER; MALE; MIDDLE AGED; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; NK T CELL LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PILOT STUDY; PRIORITY JOURNAL; SALVAGE THERAPY; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT RESPONSE; YOUNG ADULT; ADOLESCENT; ANALOGS AND DERIVATIVES; CANCER STAGING; FOLLOW UP; LYMPHOMA, EXTRANODAL NK-T-CELL; PATHOLOGY; PROGNOSIS;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEOXYCYTIDINE; DEXAMETHASONE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; LYMPHOMA, EXTRANODAL NK-T-CELL; MALE; METHOTREXATE; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; PROGNOSIS; YOUNG ADULT;

EID: 84938064842     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2014.999323     Document Type: Letter

References (15)

1. Sun J, Yang QP, Lu ZH, et al. Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification. Am J Clin Pathol 2012; 138:429-434.
2. YangQP, Zhang WY, Yu JB, et al. Subtype distribution of lymphomas in Southwest China: Analysis of 6,382 cases using WHO classification in a single institution. Diagn Pathol 2011;6:77.
3. Abouyabis AN, Shenoy PJ, Lechowicz MJ, et al. Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States. Leuk Lymphoma 2008;49:2099-2107.
4. Li YX, Yao B, Jin J, et al. Radiotherapy as primary treatment for stage IE and IIE nasal natural Killer/T-cell lymphoma. J Clin Oncol 2006;24:181-189.
5. You JY, Chi KH, Yang MH, et al. Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan. Ann Oncol 2004;15:618-625.
6. Yamaguchi M, Kita K, Miwa H, et al. Frequent expression of P-glycoprotein/MDRl by nasal T-cell lymphoma cells. Cancer 1995;76:2351-2356.
7. Li CC, Tien HF, Tang JL, et al. Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer 2004;100:366-375.
8. Jaccard A, Gachard N, Marin B, et al. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. Blood 2011;117:1834-1839.
9. Yong W, Zheng W, Zhu J, et al. L-asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type. Ann Hematol 2009;88:647-652.
10. Yamaguchi M, Kwong YL, Kim WS, et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol 2011;29:4410-4416.
11. Wang L, Wang ZH, Chen XQ, et al. First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma. Cancer 2013;119 : 348-355.
12. Lin N, Song Y, Zheng W, et al. A prospective phase II study of L-asparaginase-CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type. J Hematol Oncol 2013;6:44.
13. Ahn HK, Kim SJ, Hwang DW, et al. Gemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphoma. Invest New Drugs 2013;31:469-472.
14. Dong M, He XH, Liu P, et al. Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma. Med Oncol 2013;30:351.
15. Li L, Zhang C, Zhang L, et al. Efficacy of apegaspargase-based regimen in the treatment of newly-diagnosed extranodal natural killer/T-cell lymphoma. Neoplasma 2014;61:225-232.